A detailed history of First Horizon Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,556 shares of DXCM stock, worth $113,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,556
Previous 1,467 6.07%
Holding current value
$113,323
Previous $166,000 37.35%
% of portfolio
0.0%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$64.0 - $116.06 $5,696 - $10,329
89 Added 6.07%
1,556 $104,000
Q2 2024

Jul 19, 2024

BUY
$110.31 - $140.45 $51,294 - $65,309
465 Added 46.41%
1,467 $166,000
Q1 2024

Apr 26, 2024

BUY
$114.22 - $140.1 $6,282 - $7,705
55 Added 5.81%
1,002 $138,000
Q4 2023

Feb 06, 2024

BUY
$75.49 - $124.16 $3,095 - $5,090
41 Added 4.53%
947 $117,000
Q3 2023

Oct 27, 2023

BUY
$86.06 - $137.93 $3,958 - $6,344
46 Added 5.35%
906 $84,000
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $5,623 - $6,548
-50 Reduced 5.49%
860 $110,000
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $5,200 - $6,146
-50 Reduced 5.21%
910 $105,000
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $7,308 - $10,549
86 Added 9.84%
960 $108,000
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $1,756 - $2,166
23 Added 2.7%
874 $69,000
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $52,896 - $103,388
778 Added 1065.75%
851 $63,000
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $13,641 - $18,879
-145 Reduced 66.51%
73 $37,000
Q4 2021

Feb 09, 2022

SELL
$129.87 - $162.82 $2,467 - $3,093
-19 Reduced 8.02%
218 $29,000
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $736,725 - $988,514
-6,904 Reduced 96.68%
237 $32,000
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $739,927 - $992,810
6,934 Added 3349.76%
7,141 $976,000
Q2 2021

Aug 09, 2021

BUY
$80.99 - $107.93 $3,725 - $4,964
46 Added 28.57%
207 $22,000
Q1 2021

May 11, 2021

BUY
$84.79 - $104.74 $13,651 - $16,863
161 New
161 $14,000
Q4 2020

Feb 11, 2021

SELL
$78.0 - $104.5 $858 - $1,149
-11 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $477 - $564
-5 Reduced 31.25%
11 $1,000
Q2 2020

Jul 31, 2020

SELL
$62.68 - $105.34 $501 - $842
-8 Reduced 33.33%
16 $1,000
Q1 2020

May 05, 2020

BUY
$47.79 - $75.63 $1,146 - $1,815
24 New
24 $1,000
Q4 2017

Jan 25, 2018

SELL
$11.12 - $15.38 $3,113 - $4,306
-280 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
280
280 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.